OTCMKTS:INBP Integrated BioPharma Q3 2026 Earnings Report $0.18 +0.02 (+12.69%) As of 02:56 PM Eastern ProfileEarnings History Integrated BioPharma EPS ResultsActual EPS-$0.03Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AIntegrated BioPharma Revenue ResultsActual Revenue$10.11 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AIntegrated BioPharma Announcement DetailsQuarterQ3 2026Date5/8/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Integrated BioPharma Earnings HeadlinesIntegrated Biopharma’s Wholly-Owned Subsidiary, Manhattan Drug Company, Inc. Appoints Michael Richtmyer as Head of OperationsAugust 20, 2026 | usatoday.comIntegrated BioPharma, Inc.: Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025February 11, 2026 | finanznachrichten.deThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.September 21 at 1:00 AM | Chaikin Analytics (Ad)Integrated BioPharma Holds 2025 Annual Stockholder MeetingDecember 10, 2025 | theglobeandmail.comRentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutionsDecember 2, 2025 | globenewswire.comINBP Integrated BioPharma, Inc.June 15, 2025 | seekingalpha.comSee More Integrated BioPharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Integrated BioPharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Integrated BioPharma and other key companies, straight to your email. Email Address About Integrated BioPharmaIntegrated BioPharma (OTCMKTS:INBP), Inc. is a health and wellness company focused on the development, manufacturing and distribution of nutritional supplements, vitamins, herbal products and related consumer health offerings. The company serves businesses and consumers seeking products in the dietary supplement and natural health categories. Its activities have included contract manufacturing and private-label production, as well as the sale and distribution of finished nutritional and wellness products. These capabilities may include formulation, manufacturing, packaging and related services for supplement companies and other customers. Integrated BioPharma has historically operated in the United States and has served customers through domestic and international distribution channels. Publicly available information about its current operating structure, principal brands and leadership is limited, so additional details cannot be stated reliably.View Integrated BioPharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 5 Dividend Stocks That Combine Income, Earnings Growth, and Wall Street SupportCoach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback3 Retail Stocks Getting Crushed and the Long-Dated Options Trade on Each One3 Surging Stocks That Don’t Need the AI Boom to Keep WinningJ.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing3 Software Stocks Rebounding as AI Fears Give Way to Growth Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
